Impact of tumor size on survival outcome in metastatic renal cell carcinoma patients (mRCC) treated with targeted therapy.

被引：0
|
作者：
Xie, Wanling
DiNatale, Renzo
Hakimi, A. Ari
Donskov, Frede
Porta, Camillo
Reaume, M. Neil
Basappa, Naveen S.
Hansen, Aaron Richard
Rini, Brian I.
Beuselinck, Benoit
Bjarnason, Georg A.
Srinivas, Sandy
Brugarolas, James
Rha, Sun Young
Wood, Lori
Lalani, Aly-Khan A.
Bosse, Dominick
Duquette, Audrey
Heng, Daniel Yick Chin
Choueiri, Toni K.
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Aarhus Univ Hosp, Aarhus, Denmark
[4] IRCCS San Matteo Univ Hosp Fdn, Pavia, Italy
[5] Ottawa Hosp Canc Ctr, Ottawa, ON, Canada
[6] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
[7] Princess Margaret Canc Ctr, Toronto, ON, Canada
[8] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA
[9] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium
[10] Univ Toronto, Odette Canc Ctr, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[11] Stanford Univ, Stanford, CA USA
[12] UT Southwestern Med Ctr, Dallas, TX USA
[13] Severance Hosp, Seoul, South Korea
[14] QEII Hlth Sci Ctr, Halifax, NS, Canada
[15] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[16] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.667
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
667
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The impact of active smoking on survival outcome in metastatic renal cell carcinoma patients treated with targeted therapy.
    Li, Haoran
    Kroeger, Nils
    de Velasco, Guillermo
    Donskov, Frede
    Sim, Hao-Wen
    Wells, Connor
    Stukalin, Igor
    Agarwal, Neeraj
    Parekh, Hiral D.
    Rini, Brian I.
    Knox, Jennifer J.
    Pantuck, Allan J.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [2] Brain metastases in patients treated with targeted therapy for metastatic renal cell carcinoma (mRCC)
    Alharbi, H.
    Choueiri, T. K.
    Kollmannsberger, C. K.
    North, S.
    MacKenzie, M. J.
    Knox, J. J.
    Rini, B. I.
    Heng, D. Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [3] Outcome of patients with metastatic renal cell carcinoma (mRCC) treated with targeted therapy (TT) without cytoreductive nephrectomy (CN)
    Richey, S. L.
    Culp, S. H.
    Jonasch, E.
    Corn, P. G.
    Pagliaro, L. C.
    Matin, S. F.
    Wood, C. G.
    Tannir, N. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
    Song Yan
    Du Chun-Xia
    Zhang Wen
    Sun Yong-Kun
    Yang Lin
    Cui Cheng-Xu
    Chi Yihe-Bali
    Shou Jian-Zhong
    Zhou Ai-Ping
    Li Chang-Ling
    Ma Jian-Hui
    Wang Jin-Wan
    Sun Yan
    [J]. 中华医学杂志(英文版), 2016, 129 (05) : 530 - 535
  • [5] Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy
    Kawashima, Atsunari
    Tsujimura, Akira
    Takayama, Hitoshi
    Arai, Yasuyuki
    Nin, Mikio
    Tanigawa, Go
    Uemura, Motohide
    Nakai, Yasutomo
    Nishimura, Kazuo
    Nonomura, Norio
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (12) : 1050 - 1057
  • [6] IMPACT OF HYPONATREMIA ON SURVIVAL OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH MOLECULAR TARGETED THERAPY
    Kawashima, Atsunari
    Takayama, Hitoshi
    Arai, Yasuyuki
    Nin, Mikio
    Tanigawa, Go
    Yasunaga, Yutaka
    Mukai, Masatoshi
    Nomura, Hironori
    Oka, Daizo
    Yoshioka, Toshiaki
    Fukuda, Satoko
    Nishimura, Kenji
    Murosaki, Nobukazu
    Koga, Minoru
    Kojima, Yasuyuki
    Kyakuno, Miyaji
    Yoshida, Takahiro
    Hatano, Koji
    Sato, Mototaka
    Uemura, Motohide
    Nakai, Yasutomo
    Nishimura, Kazuo
    Tsujimura, Akira
    Nonomura, Norio
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E806 - E806
  • [7] Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
    Song, Yan
    Du, Chun-Xia
    Zhang, Wen
    Sun, Yong-Kun
    Yang, Lin
    Cui, Cheng-Xu
    Chi, Yihe-Bali
    Shou, Jian-Zhong
    Zhou, Ai-Ping
    Li, Chang-Ling
    Ma, Jian-Hui
    Wang, Jin-Wan
    Sun, Yan
    [J]. CHINESE MEDICAL JOURNAL, 2016, 129 (05) : 530 - 535
  • [8] The impact of weight change during treatment with targeted therapy in patients with metastatic renal cell carcinoma (mRCC).
    Albiges, Laurence
    Mckay, Rana R.
    Lin, Xun
    de Velasco, Guillermo
    Simantov, Ronit
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [9] OVERALL SURVIVAL (OS) IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS' SEQUENTIALLY TREATED WITH TARGETED THERAPIES (TTS)
    Procopio, G.
    Verzoni, E.
    Testa, I.
    de Braud, F.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 24 - 24
  • [10] Outcome of metastatic renal cell carcinoma (mRCC) patients in the era of new targeted therapies
    Ruiz, A. L.
    Bolos, M. V.
    Viqueira, A.
    Esteban, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S654 - S654
12345